Gopichand Gutti

Gopichand Gutti works on computer-aided drug discovery, designing and evaluating new chemical compounds for diseases such as Alzheimer's disease and cancer. Much of the work combines computational methods like molecular docking, molecular dynamics simulation, and machine learning with laboratory synthesis and biological testing to find molecules that inhibit disease-related proteins (e.g., cholinesterases, BACE-1, GSK-3β). The research also touches on natural-product-based treatments and drug design strategies for viral and bacterial infections.

Publication output has been relatively steady over the past decade, with a peak in 2019, a dip in 2020, and a fairly consistent output of 2-4 papers per year since then.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026